Interacting Drugs |
Butalbital compound vs Calcium Channel Blockers (Nondihydropyridine) |
Security Level |
|
Mechanism |
Calcium Channel Blockers (Nondihydropyridine): May enhance the anticoagulant effect of Salicylates. Exceptions: Bepridil [Off Market]. |
Management |
Monitor therapy |
Butalbital compound vs Calcium Channel Blockers (Nondihydropyridine)
Post Review about Butalbital compound vs Calcium Channel Blockers (Nondihydropyridine) Click here to cancel reply.
Other Interactions of Butalbital compound
Other Interactions of Calcium Channel Blockers (Nondihydropyridine)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.